DaVita Inc. $DVA Shares Sold by Gotham Asset Management LLC

Key Points

• Gotham Asset Management LLC reduced its holdings in DaVita Inc. by 19.5%, selling 25,566 shares, and now owns approximately 0.14% of the company valued at $16.18 million.
• DaVita reported $2.95 EPS exceeding analysts' expectations during its latest earnings call, alongside a 6.1% revenue increase year-over-year.
• Several institutional investors have recently modified their positions in DaVita, with institutional ownership now at 90.12% of the company's stock.

Gotham Asset Management LLC lowered its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 19.5% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 105,779 shares of the company's stock after selling 25,566 shares during the period. Gotham Asset Management LLC owned about 0.14% of DaVita worth $16,181,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Fifth Third Bancorp raised its stake in shares of DaVita by 5.0% during the 1st quarter. Fifth Third Bancorp now owns 4,274 shares of the company's stock valued at $654,000 after buying an additional 204 shares during the last quarter. Concurrent Investment Advisors LLC purchased a new position in shares of DaVita during the 1st quarter valued at about $223,000. Wealth Enhancement Advisory Services LLC raised its stake in shares of DaVita by 22.5% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 4,351 shares of the company's stock valued at $666,000 after buying an additional 800 shares during the last quarter. Envestnet Asset Management Inc. raised its stake in shares of DaVita by 7.9% during the 1st quarter. Envestnet Asset Management Inc. now owns 55,255 shares of the company's stock valued at $8,452,000 after buying an additional 4,048 shares during the last quarter. Finally, OneDigital Investment Advisors LLC purchased a new position in shares of DaVita in the 1st quarter valued at about $200,000. Hedge funds and other institutional investors own 90.12% of the company's stock.

Insider Buying and Selling at DaVita

In other DaVita news, insider James O. Hearty sold 2,351 shares of the business's stock in a transaction dated Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total value of $352,650.00. Following the transaction, the insider directly owned 26,038 shares in the company, valued at $3,905,700. The trade was a 8.28% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 1.50% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts recently weighed in on DVA shares. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a research note on Friday, August 22nd. Truist Financial set a $148.00 price target on DaVita in a research note on Friday, August 8th. Barclays cut their price target on DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a research note on Thursday, August 7th. Finally, Bank of America cut their target price on shares of DaVita from $145.00 to $140.00 and set an "underperform" rating for the company in a research note on Wednesday. Three equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Reduce" and an average target price of $158.00.

DaVita Price Performance

Shares of NYSE DVA traded up $1.40 during mid-day trading on Thursday, reaching $133.66. The company's stock had a trading volume of 149,880 shares, compared to its average volume of 847,969. The stock has a 50-day moving average of $138.83 and a two-hundred day moving average of $141.66. The stock has a market capitalization of $9.56 billion, a P/E ratio of 13.14, a P/E/G ratio of 0.98 and a beta of 1.13. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.34 and a current ratio of 1.39. DaVita Inc. has a 1-year low of $126.07 and a 1-year high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, topping the consensus estimate of $2.70 by $0.25. The business had revenue of $3.38 billion for the quarter, compared to analysts' expectations of $3.36 billion. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The business's revenue for the quarter was up 6.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.00 EPS. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. On average, equities research analysts anticipate that DaVita Inc. will post 10.76 EPS for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.